genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Eye Disorders
Prime Editing Reverses Vision Loss in Mice
Artificial Intelligence
AI-Proofing Workflows in Drug Development
Cancer
New Drug Combo Reduces Lung Tumors in Mice
AgBio
Gene Discovery May Help Effort to Breed Climate Resilient Crops
Cancer
Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Cancer
Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity
Biologics
Biologics Manufacturing without the Cells
Bioprocessing
Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production
Bioprocessing
Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Neurological Disorders
ALS
ALS
ALS
Alzheimers
Mental Health Disorders
Parkinsons
Schizophrenia
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ALS
Innate Immune Molecule Implicated in ALS Neurodegeneration
ALS
Stress Test: ProJenX’s Oral Drug Shows Early Promise vs. ALS
Neurological Disorders
Neumora Completes $112M Series B to Develop Precision Neuro Therapies
ALS
StockWatch: Despite Approval in ALS, Amylyx Sees No Price Surge
Nanotechnology
Clene Energy: Nanocrystal Developer Pursues Remyelination vs. MS, ALS
ALS
Longer-Term Use of Investigational Drug Stabilizes ALS Symptoms
ALS
Repurposed Drug Shows Preclinical Promise against Amyotrophic Lateral Sclerosis
ALS
StockWatch: Investors Warm to Amylyx as FDA Panel Revisits ALS Drug
Financing
StockWatch: Layoffs Fail to Lift Novartis
ALS
Triple Threat: NeuroSense Targets ALS
Neurological Disorders
StockWatch: Praxis Shares Crater 75% as Aria Strikes a Sour Note
Neurological Disorders
StockWatch: ALS Setback Hammers Amylyx, Longeveron Doubles on Positive Alzheimer’s Data
ALS
ALS-Linked TDP-43 Aggregates Seen Clearly Enough to Raise Treatment Hopes
ALS
Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction
Sponsored
Working with ALS Mice: Guidelines for Preclinical Testing and Colony Management
1
2
3
4
Page 1 of 4
Scroll Up
